Journal
PROTEOMICS
Volume 11, Issue 5, Pages 829-842Publisher
WILEY
DOI: 10.1002/pmic.201000194
Keywords
Bromination; CNBr; Near-isobaric modifications; Phosphorylation; Technology; Topoisomerase II beta
Funding
- United States Public Health Service [RO1 CA 117928]
- CNCSIS [ID-249 168/2007, POSDRU/89/1.5/S/60746]
Ask authors/readers for more resources
Topoisomerase (topo) II catalyzes topological changes in DNA. Although both human isozymes, topo II alpha and beta are phosphorylated, site-specific phosphorylation of topo II beta is poorly characterized. Using LC-MS/MS analysis of topo II beta, cleaved with trypsin, Arg C or cyanogen bromide (CNBr) plus trypsin, we detected four +80-Da modified sites: tyr656, ser1395, thr1426 and ser1545. Phosphorylation at ser1395, thr1426 and ser1545 was established based on neutral loss of H3PO4 (-98 Da) in the CID spectra and on differences in 2-D-phosphopeptide maps of P-32-labeled wild-type (WT) and S1395A or T1426A/S1545A mutant topo II beta. However, phosphorylation at tyr656 could not be verified by 2-D-phosphopeptide mapping of P-32-labeled WT and Y656F mutant protein or by Western blotting with phosphotyrosine-specific antibodies. Since the +80-Da modification on tyr656 was observed exclusively during cleavage with CNBr and trypsin, this modification likely represented bromination, which occurred during CNBr cleavage. Re-evaluation of the CID spectra identified +78/+80-Da fragment ions in CID spectra of two peptides containing tyr656 and tyr711, confirming bromination. Interestingly, mutation of only tyr656, but not ser1395, thr1326 or ser1545, decreased topo II beta activity, suggesting a functional role for tyr656. These results, while identifying an important tyrosine in topo II beta, underscore the importance of careful interpretation of modifications having the same nominal mass.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available